β-D-Glucopyranosiduronic acid, 4-(methylnitrosoamino)-1-(3-pyridinyl)butyl
| Title | Journal |
|---|---|
| Stereospecific Metabolism of the Tobacco-Specific Nitrosamine, NNAL. | Chemical research in toxicology 20151116 |
| Microfluidic direct injection method for analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) using molecularly imprinted polymers coupled on-line with LC-MS/MS. | Journal of pharmaceutical and biomedical analysis 20110125 |
| Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. | International journal of cancer 20091115 |
| Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20090101 |
| A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20090101 |
| Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20080301 |
| Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats. | Carcinogenesis 20071201 |
| Smokeless tobacco brand switching: a means to reduce toxicant exposure? | Drug and alcohol dependence 20070316 |
| A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer. | Preventive medicine 20061001 |
| Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes. | Pharmacogenetics and genomics 20051101 |
| Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20050501 |
| Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). | Cancer 20050401 |
| Children's exposure to environmental tobacco smoke: using diverse exposure metrics to document ethnic/racial differences. | Environmental health perspectives 20040301 |
| Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes. | Cancer research 20040201 |
| Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20031201 |
| Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. | Chemical research in toxicology 20020401 |
| Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. | Cancer research 20020101 |
| Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20011101 |
| Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. | Journal of the National Cancer Institute 20010307 |